Extract from the Register of European Patents

EP About this file: EP0674515

EP0674515 - The use of carbostyril derivatives for the preparation of a medicament for the inhibition of Interleukin-8 [Right-click to bookmark this link]
Former [1995/40]CARBOSTYRIL DERIVATIVE FOR INHIBITING PRODUCTION OF INTERLEUKIN-8
[1999/08]
StatusNo opposition filed within time limit
Status updated on  21.07.2000
Database last updated on 10.03.2026
Most recent event   Tooltip21.07.2000No opposition filed within time limitpublished on 06.09.2000 [2000/36]
Applicant(s)For all designated states
OTSUKA PHARMACEUTICAL CO., LTD.
9, Kanda-Tsukasacho 2-chome Chiyoda-ku
Tokyo 101 / JP
[N/P]
Former [1995/40]For all designated states
OTSUKA PHARMACEUTICAL CO., LTD.
9, Kanda-Tsukasacho 2-chome
Chiyoda-ku Tokyo 101 / JP
Inventor(s)01 / MATSUDA, Takahide
1-14-18, Shiratori Asao-ku Kawasaki-shi
Kanagawa 215 / JP
02 / OWADA, Shigeru
4-11-14, Kichijoji-honcho Musashino-shi
Tokyo 180 / JP
03 / MUTA, Hiroshi
19-45-205, Midorigaokacho Ashiya-shi
Hyogo 659 / JP
04 / AIHARA, Miki
Sezyuru Hamada 1-104 34, Aza Maesu Nakamura
Kitajimacho, Itano-gun Tokushima 771-02 / JP
05 / TAKIZAWA, Hisao
697-34, Nagagishi Matsushigecho
Itano-gun Tokushima 771-02 / JP
06 / IMAGAWA, Ken-ichi
1-83, Aza Kitahari Shinkirai
Kitajimacho Itano-gun Tokushima 771-02 / JP
07 / KIKUCHI, Mikio
4-29-14, Imaizumidai Kamakura-shi
Kanagawa 247 / JP
[1995/40]
Representative(s)Ruffles, Graham Keith
Marks & Clerk LLP 62-68 Hills Road Cambridge
CB2 1LA / GB
[N/P]
Former [1995/40]Ruffles, Graham Keith
MARKS & CLERK, 57-60 Lincoln's Inn Fields
London WC2A 3LS / GB
Application number, filing date94929670.117.10.1994
[1995/40]
WO1994JP01739
Priority number, dateJP1993026341721.10.1993         Original published format: JP 26341793
JP1993026341821.10.1993         Original published format: JP 26341893
JP1993026341921.10.1993         Original published format: JP 26341993
JP1994008964127.04.1994         Original published format: JP 8964194
[1995/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9511026
Date:27.04.1995
Language:EN
[1995/18]
Type: A1 Application with search report 
No.:EP0674515
Date:04.10.1995
Language:EN
The application published by WIPO in one of the EPO official languages on 27.04.1995 takes the place of the publication of the European patent application.
[1995/40]
Type: B1 Patent specification 
No.:EP0674515
Date:22.09.1999
Language:EN
[1999/38]
Search report(s)International search report - published on:EP27.04.1995
ClassificationIPC:A61K31/47
[1995/40]
CPC:
A61K31/47 (EP,KR,US); A61P1/02 (EP); A61P13/12 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1995/40]
TitleGerman:Die Verwendung von Carbostyrilderivaten zur Herstellung eines Arzneimittels zur Hemmung der Produktion von Interleukin-8[1999/08]
English:The use of carbostyril derivatives for the preparation of a medicament for the inhibition of Interleukin-8[1999/08]
French:Utilisation des dérivés de carbostyryle pour l'obtention d'un medicament destiné à inhiber la production de l'interleukine 8[1999/08]
Former [1995/40]CARBOSTYRILDERIVAT ZUR HEMMUNG DER INTERLEUKIN-8-PRODUKTION
Former [1995/40]CARBOSTYRIL DERIVATIVE FOR INHIBITING PRODUCTION OF INTERLEUKIN-8
Former [1995/40]DERIVE DE CARBOSTYRYLE INHIBANT LA PRODUCTION D'INTERLEUKINE-8
Entry into regional phase05.06.1995National basic fee paid 
05.06.1995Designation fee(s) paid 
05.06.1995Examination fee paid 
Examination procedure05.06.1995Examination requested  [1995/40]
05.12.1997Despatch of a communication from the examining division (Time limit: M04)
13.03.1998Reply to a communication from the examining division
29.05.1998Despatch of a communication from the examining division (Time limit: M04)
09.09.1998Reply to a communication from the examining division
24.09.1998Despatch of a communication from the examining division (Time limit: M02)
16.11.1998Reply to a communication from the examining division
25.11.1998Despatch of a communication from the examining division (Time limit: M02)
24.12.1998Reply to a communication from the examining division
15.01.1999Despatch of communication of intention to grant (Approval: Yes)
30.03.1999Communication of intention to grant the patent
11.06.1999Fee for grant paid
11.06.1999Fee for publishing/printing paid
Opposition(s)24.06.2000No opposition filed within time limit [2000/36]
Fees paidRenewal fee
09.10.1996Renewal fee patent year 03
10.10.1997Renewal fee patent year 04
12.10.1998Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY] JPH0374329   [Y] 17-48
 [Y] JPS63119467  
 [Y] JPH02178227  
 [XY]   T. YOSHIKAWA ET AL.: "Free radical scavenging activity of the novel anti-ulcer agent Rebamipide studied by electron spin resonance", ARZNEIMITTELFORSCHUNG, vol. 43, no. 3, March 1993 (1993-03-01), pages 363 - 366 [X] 1-18,21,22 * the whole document * [Y] 17-48
 [PXY]   SUZUKI M ET AL: "[Role of ammonia-monochloramine system in Helicobacter pylori--induced gastric mucosal injury]", NIPPON RINSHO (JAPAN), DEC 1993, VOL. 51, NO. 12, PAGE(S) 3154-8, [PX] 1-18,21,22 * abstract *[Y] 17-48
 [XY]   KISHIMOTO S ET AL: "Therapeutic effects of oral rebamipide and in combination with cimetidine on experimental gastritis in rats.", RES COMMUN CHEM PATHOL PHARMACOL (UNITED STATES), DEC 1992, VOL. 78, NO. 3, PAGE(S) 259-77, [X] 1-16 * the whole document *[Y] 17-48
 [XY]   PATENT ABSTRACTS OF JAPAN vol. 15, no. 238 (C - 841)<4766> 19 June 1991 (1991-06-19) [X] 1-16 * abstract *[Y] 17-48
 [Y]   DATABASE WPI Week 8826, Derwent World Patents Index; AN 88-180572 [Y] 17-20,27-30 * abstract *
 [Y]   PATENT ABSTRACTS OF JAPAN vol. 14, no. 453 (C - 764)<4396> 28 September 1990 (1990-09-28) [Y] 19,20,37,38,45,46 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.